about
VARC consensus report: the FDA perspective.Clinical Trial Principles and Endpoint Definitions for Paravalvular Leaks in Surgical Prosthesis: An Expert Statement.US FDA perspective on regulatory issues affecting circulatory assist devices.FDA perspective on clinical trial design for cardiovascular devices.Hyperthermic preconditioning protects against spinal cord ischemic injurySixty-year perspective on coronary artery bypass grafting in womenVARC consensus report: the FDA perspective
P50
Q34492683-e1b1101d-4ed5-bb99-63b1-013656d25318Q38692282-d8012dfb-42e0-9eca-ba3c-4bb2b9ef7299Q51071361-e3c3fcce-45b4-d40f-4f39-4dc72cef6450Q51141758-6116379e-4549-707b-e6f7-15f6279b05cdQ73228853-0d0b7ac4-42d6-0dcf-d166-bf143ffe2d3dQ79075359-32bd60ed-41ad-cbcf-44da-505c44afa625Q83154079-f304e8a1-4de8-be4c-63bb-677fd6bbff8b
P50
description
American cardiac surgeon
@en
hartchirurg
@nl
name
Julie Swain
@ast
Julie Swain
@en
Julie Swain
@es
Julie Swain
@nl
type
label
Julie Swain
@ast
Julie Swain
@en
Julie Swain
@es
Julie Swain
@nl
altLabel
Julie A Swain
@en
Julie A. Swain
@en
Julie Ann Swain
@en
prefLabel
Julie Swain
@ast
Julie Swain
@en
Julie Swain
@es
Julie Swain
@nl
P108
P106
P108
P1153
7102441762